Shropshire, Telford and Wrekin Community and Hospitals NHS Group is the agreed alliance, working in partnership, between The Shropshire Community Health NHS Trust and The Shrewsbury and Telford Hospital NHS Trust, which remain the statutory organisations.

As a Group, our Boards meet in Common and our members are:

Andrew Morgan – Group Chair
Jo Williams – Group Chief Executive

Non-Executive Directors

Every NHS Trust Board must have a majority of lay people on the Board, including the Chairman and Non-Executive Directors. They are appointed from the local community served by the Trust, and their responsibilities include:

• helping the board to work in the public interest and keep its patients and the public properly informed
• helping to plan for the future to improve healthcare services
• making sure that the management team meets its performance targets
• making sure that the finances of the organisation are managed properly, with accurate information.

Each Non-Executive Director also brings individual skills and personal experience of their community and the NHS to guide the work of the Trust.

The Non-Executive Directors are:

• Tina Long
• Harmesh Darbhanga
• Cathy Purt
• Jill Barker
• Vacancy
• Prof Trevor Purt
• Teresa Boughey
• Rajinder Dhaliwal
• Rosi Edwards
• Richard Miner
• Sarah Dunnett
• Wendy Nicholson MBE 
• Simon Crowther (Associate) 
• Prof Heidi Fuller (Associate)
• Jon Sargeant (Associate)

Executive Directors

The Executive Directors are experts led by a Group Chief Executive. Each Executive has their own clinical/functional responsibilities (e.g. medical, finance) as well as being a corporate member of the Board.

The Voting Executive Directors of the Group Board are:

• Dr John Jones – Group Chief Medical Officer
• Paula Gardner –Group Chief Nursing Officer (Interim)
• Ned Hobbs – Group Chief Operating Officer and Deputy Chief Executive (SaTH)
• Adam Winstanley – Acting Chief Finance Officer (SaTH)
• Sarah Lloyd – Acting Chief Finance Officer and Deputy Chief Executive (ShropCom)

Non-voting Directors:

• Nigel Lee – Group Chief Strategy and Integration Officer
• Rhia Boyode – Group Chief People Officer
• Anna Milanec – Group Chief Governance Officer
• Matthew Neal – Group Chief Estates, Facilities and Capital Officer
• Jennifer Fullard-Slawson – Group Chief Communications Officer
• Tracey Cotterill – Group Chief Recovery and Transformation Officer (until July 2026).

Useful Documents

Responsibilities of the Trust Board and how we are regulated

---

A Statement about the balance, completeness, and appropriateness of the Board – March 2025

The original Establishment Order (2003) for the Trust advised that “the Board shall have, in addition to the chairman, 5 executive and 6 non-executive directors”, making a total of twelve voting board directors at that time.

In November 2004, an Amendment to the original Establishment Order updated the number of non-executive directors to seven, in addition to the Chairman, making a total of 13 voting board directors. This composition has continued to the current day, with the addition of several non-voting executive and non-voting non-executive directors (the latter being known as ‘associate non-executive directors’) being part of the wider board, and attending the board meetings, board activities and board development.

During the 2024/2025 financial year, there have been several changes to the Board personnel, i.e. appointment of a Chair-in-Common (together with Shropshire Community Health NHS Trust (‘ShropCom’)) in place of the former Trust Chair, and the transition of an existing experienced, associate non-executive director to a “full” voting non-executive director following the end of the  term of office of an existing non-executive director.

With regard to our executive team, the Trust welcomed a new Chief Executive (currently interim) in September 2024, a Chief Nursing Officer (currently interim), and a Chief Operating Officer.

In addition, and in common with evolving structures across the NHS, our People and OD Director now splits her time between the Trust and ShropCom, and our Director of Strategy and Partnerships has also taken on a split role with the STW ICS as their Chief Strategy Officer.

There is a clear separation of the roles of the Chair-in-Common and the Chief Executive.  The Chair has responsibility for the running of the Board, setting the agenda and for ensuring that all directors are fully informed of matters relevant to their roles. The Chief Executive has responsibility for implementing the strategies agreed by the Board and for managing the day-to-day business of the Trust, together with her executive team.

The Board of Directors regularly reviews its effectiveness and that of its assurance committees and believes that the Trust is led by an effective Board; the Board is collectively responsible for the exercise of the performance of the Trust, the setting of culture, and the setting of its strategy. No individual group or individuals dominate the meetings of the Board.

The Board considers that the Non-Executive Directors bring a wide range of business, commercial, financial and clinical knowledge required for the successful direction of the Trust.

All the Non-Executive Directors are considered to be independent in accordance with the Code of Governance for NHS provider trusts.

All directors are subject to an annual review of their performance and contribution to the management and leadership of the Trust.

Diversity is a vital part of the continued assessment and enhancement of board composition, and the Board recognises the benefits of diversity amongst its members.

At the present time, the Board is satisfied as to its balance, completeness and appropriateness and will keep these matters under review, in conjunction with NHS England who are responsible for appointing chairs and other non-executive directors of NHS Trusts.